Hello, welcome to the official website!
Contact Phone:400-000-0000
- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
28
2020-06
Kintor Pharmaceutical Signs Strategic Cooperation Agreement with JD Pharmacy
Kintor Pharmaceutical Limited announced that it has signed a strategic cooperation framework agreement with JD Pharmacy, the pharmaceutical retail channel under JD Health, in a concerted effort to create a patient-centred online innovative healthcare ecosystem. JD Pharmacy will utilise its abundant traffic and resources and strong technological and supply chain capabilities to assist Kintor Pharmaceutical in the marketing and sales of the innovative External use drug KX-826.
22
2020-05
Kintor Pharmaceutical successfully listed on HKEX today
Kintor Pharmaceutical Limited (Stock Code:9939.HK) has successfully been listed on the Main Board of the Stock Exchange of Hong Kong Limited on 22,May 2020.
19
2020-05
On the last day of 2019, Kintor’s application for a HKEX listing had attracted industry attention. It was reported that with this Hong Kong stock IPO listing on May 22nd 2020 and the global sale of 92
09
2020-05
In 2008, as the first group of pioneers to return to China to conduct research on small molecule anticancer drugs, Dr. Youzhi Tong said, there were not many companies doing new drug research and devel
07
2020-05
Ten years of consistent effort finally bear fruit
In 2008, after nearly 20 years studying and working in the US, Dr. Youzhi Tong made a momentous decision to return to China and start a new drug discovery company. “People who choose to start a busine
16
2020-04
Kintor pharmaceutical and Sinopharm signed a strategic cooperation agreement
Suzhou Kintor Pharmaceutical ,Inc. ("Kintor Pharmaceutical ")and Sinopharm Holding Co., Ltd. signed the strategic cooperation agreement on the innovation of topical drug Pyrilutamide (KX-826) in Shanghai. Both sides carry out all-round cooperation on patient-centered product design, future business channel development and terminal services, so as to prepare for future market development and better service for patients.
Find Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Complaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor.com.cn
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Powered by 300.cn